FDA could add a more visual symbol of its approval of REMS materials and communications in order to entice more providers to read them, members of the agency’s Risk Communication Advisory Committee suggested Dec. 17.
FDA is looking to improve Risk Evaluation and Mitigation Strategies’ impact among providers, including better efforts to ensure that “Dear...